The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Influence of molecular imaging on patient selection for treatment intensification prior to salvage radiation therapy for prostate cancer: A post hoc analysis of the PROPS trial.
 
Samuel Tremblay
No Relationships to Disclose
 
Mofarej Alhogbani
No Relationships to Disclose
 
Andrew Weickhardt
No Relationships to Disclose
 
Ian D. Davis
Research Funding - Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Exelixis (Inst); Ipsen (Inst); Janssen Oncology (Inst); Medivation (Inst); Movember Foundation (Inst); MSD Oncology (Inst); Pfizer (Inst); Roche/Genentech (Inst); Seagen (Inst)
Patents, Royalties, Other Intellectual Property - International Patent Application No: PCT /US2004/032147 (NY-ESO-1) through Ludwig Institute for Cancer Research.
 
Andrew Mark Scott
Research Funding - Adalta (Inst); Antengene (Inst); AstraZeneca (Inst); AVID/Lilly (Inst); Curis (Inst); Cyclotek (Inst); EMD Serono (Inst); Fusion Pharmaceuticals (Inst); Humanigen (Inst); Isotopen Technologien (Inst); Merck (Inst); Telix Pharmaceuticals (Inst)
Patents, Royalties, Other Intellectual Property - Patents relating to antibodies to EGFR, HER2, PDGF-CC, FN-14, GM-CSF, EPhA3 (Inst)
 
Rodney J. Hicks
Stock and Other Ownership Interests - Telix Pharmaceuticals
Consulting or Advisory Role - Revela
 
Ur Metser
Employment - POINT Biopharma
Consulting or Advisory Role - POINT Biopharma
 
Sue Chua
No Relationships to Disclose
 
Reena Davda
No Relationships to Disclose
 
Shonit Punwani
No Relationships to Disclose
 
Heather Ann Payne
Honoraria - AAA/Endocyte/Novartis; Astellas Pharma; AstraZeneca; Bayer; Ferring; FERRING; Janssen-Cilag
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Janssen-Cilag
Speakers' Bureau - Astellas Pharma; Bayer; Janssen-Cilag
Research Funding - Astellas Pharma (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Janssen-Cilag
 
Nina Tunariu
No Relationships to Disclose
 
Bao Ho
No Relationships to Disclose
 
Sympascho Young
No Relationships to Disclose
 
Glenn Bauman
No Relationships to Disclose
 
Louise Emmett
Honoraria - Astellas Pharma; AstraZeneca; Janssen Oncology; Mundipharma; Telix Pharmaceuticals
Consulting or Advisory Role - Noxopharm
Speakers' Bureau - Janssen Oncology; Janssen Oncology; mundipharma
Research Funding - Novartis (Inst); Novartis (Inst); Noxopharm (Inst); Noxopharm (Inst)
 
Frederic Pouliot
No Relationships to Disclose